Stay updated on Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:23:09.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-12T02:29:05.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:46:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary feature has been added to the page, and the page now displays the label 'Last Update Submitted that Met QC Criteria' along with revision 'v3.4.0'. The previous label 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' entry, and the prior revision 'v3.3.4' were updated to reflect capitalization and version updates.
    Difference
    0.2%
    Check dated 2026-01-28T20:28:31.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.3.3 to v3.3.4. This appears to be a metadata update with no visible changes to study content.
    Difference
    0.1%
    Check dated 2026-01-14T03:59:57.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section showing Houston, Texas as a study site. The update also updates the revision from v3.3.2 to v3.3.3 and removes the old 'Texas Locations' header as well as the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T22:22:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.